Literature DB >> 27408203

Fetal Anomalies in Rheumatoid Arthritis Patient Exposed to Low Dose Methotrexate.

Y Singh1, A Shankar2.   

Abstract

Entities:  

Keywords:  Fetal anomalies; Methotrexate

Year:  2011        PMID： 27408203      PMCID： PMC4921519          DOI： 10.1016/S0377-1237(09)80068-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  5 in total

Review 1.  The effects of methotrexate on pregnancy, fertility and lactation.

Authors:  M E Lloyd; M Carr; P McElhatton; G M Hall; R A Hughes
Journal:  QJM       Date:  1999-10

Review 2.  Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future.

Authors:  Fokaline Vroom; Hermien E K de Walle; Mart A J F van de Laar; Jacobus R B J Brouwers; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Treating early rheumatoid arthritis in the younger patient.

Authors:  B Bresnihan
Journal:  J Rheumatol Suppl       Date:  2001-06

4.  Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester.

Authors:  Christine Nguyen; Adam J Duhl; Cathleen S Escallon; Karin J Blakemore
Journal:  Obstet Gynecol       Date:  2002-04       Impact factor: 7.661

5.  Prenatal diagnosis of methotrexate embryopathy.

Authors:  Jeff B Chapa; Judith U Hibbard; Elyse M Weber; Jacques S Abramowicz; Marion S Verp
Journal:  Obstet Gynecol       Date:  2003-05       Impact factor: 7.661
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.